Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
26 Landsdowne Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 543 % +8.81%
Debt-to-equity 56.8 % -29.8%
Return On Equity -15.5 % +63.2%
Return On Assets -9.86 % +57.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.3 M shares +8%
Common Stock, Shares, Outstanding 82.3 M shares +10.5%
Entity Public Float 2.11 B USD -14.2%
Common Stock, Value, Issued 823 K USD +10.6%
Weighted Average Number of Shares Outstanding, Basic 81.7 M shares +13%
Weighted Average Number of Shares Outstanding, Diluted 81.7 M shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 361 M USD +371%
Research and Development Expense 423 M USD +22.2%
General and Administrative Expense 120 M USD +30.4%
Operating Income (Loss) -182 M USD +49.7%
Nonoperating Income (Expense) 48.3 M USD -34.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -260 M USD +29.8%
Income Tax Expense (Benefit) 1.37 M USD -59.9%
Net Income (Loss) Attributable to Parent -135 M USD +57.4%
Earnings Per Share, Basic -1.6 USD/shares +64%
Earnings Per Share, Diluted -1.6 USD/shares +64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 288 M USD +15.2%
Marketable Securities, Current 807 M USD -0.37%
Cash, Cash Equivalents, and Short-term Investments 1.1 B USD 0%
Assets, Current 1.12 B USD +3.57%
Property, Plant and Equipment, Net 121 M USD -0.74%
Operating Lease, Right-of-Use Asset 109 M USD -6.14%
Other Assets, Noncurrent 1.69 M USD +9.82%
Assets 1.36 B USD +2.06%
Accounts Payable, Current 2.79 M USD -80.2%
Employee-related Liabilities, Current 4.89 M USD -13.1%
Contract with Customer, Liability, Current 72.1 M USD -49.5%
Liabilities, Current 187 M USD -14.9%
Contract with Customer, Liability, Noncurrent 99.6 M USD -42%
Operating Lease, Liability, Noncurrent 156 M USD -5.66%
Other Liabilities, Noncurrent 719 K USD +316%
Liabilities 446 M USD -21.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -921 K USD -20.4%
Retained Earnings (Accumulated Deficit) -1.29 B USD -11.7%
Stockholders' Equity Attributable to Parent 913 M USD +20%
Liabilities and Equity 1.36 B USD +2.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.7 M USD +9.17%
Net Cash Provided by (Used in) Financing Activities 2.9 M USD -97.1%
Net Cash Provided by (Used in) Investing Activities -53.5 M USD -310%
Common Stock, Shares Authorized 250 M shares 0%
Common Stock, Shares, Issued 82.3 M shares +10.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -150 M USD -1170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 294 M USD +13.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14 K USD -77.4%
Deferred Tax Assets, Valuation Allowance 329 M USD +29.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 366 M USD +23.3%
Operating Lease, Liability 173 M USD -3.53%
Depreciation 20.8 M USD +34.3%
Payments to Acquire Property, Plant, and Equipment 2.44 M USD -59.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -135 M USD +57.1%
Lessee, Operating Lease, Liability, to be Paid 251 M USD -6.22%
Property, Plant and Equipment, Gross 177 M USD +12.7%
Operating Lease, Liability, Current 12.2 M USD +9.18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.3 M USD +3.53%
Lessee, Operating Lease, Liability, to be Paid, Year One 25 M USD +15.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 78.6 M USD -11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22.5 M USD -10%
Deferred Tax Assets, Operating Loss Carryforwards 3.96 M USD -84.6%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 1.4 M USD -58.8%
Preferred Stock, Shares Authorized 25 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.2 M USD +4.21%
Operating Lease, Payments 22.6 M USD +18.6%
Additional Paid in Capital 2.2 B USD +15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.43 M USD +16.9%
Share-based Payment Arrangement, Expense 104 M USD +15.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%